Altimmune to announce year end 2020 financial results on february 25, 2021

Gaithersburg, md., feb. 22, 2021 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its full year 2020 financial results on thursday, february 25th, 2021.

ALT Ratings Summary

ALT Quant Ranking